vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and Rhinebeck Bancorp, Inc. (RBKB). Click either name above to swap in a different company.

ADC Therapeutics SA is the larger business by last-quarter revenue ($23.1M vs $13.5M, roughly 1.7× Rhinebeck Bancorp, Inc.). On growth, Rhinebeck Bancorp, Inc. posted the faster year-over-year revenue change (1701.1% vs 36.4%). Over the past eight quarters, Rhinebeck Bancorp, Inc.'s revenue compounded faster (14.0% CAGR vs 13.7%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

Rhinebeck Bancorp, Inc. is a US regional bank holding company based in New York. It operates Rhinebeck Bank, offering retail and commercial banking services including deposit accounts, loans, mortgages and wealth management, mainly serving consumers and small-to-medium businesses across New York's Hudson Valley region.

ADCT vs RBKB — Head-to-Head

Bigger by revenue
ADCT
ADCT
1.7× larger
ADCT
$23.1M
$13.5M
RBKB
Growing faster (revenue YoY)
RBKB
RBKB
+1664.7% gap
RBKB
1701.1%
36.4%
ADCT
Faster 2-yr revenue CAGR
RBKB
RBKB
Annualised
RBKB
14.0%
13.7%
ADCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ADCT
ADCT
RBKB
RBKB
Revenue
$23.1M
$13.5M
Net Profit
$2.3M
Gross Margin
Operating Margin
-77.7%
21.7%
Net Margin
17.3%
Revenue YoY
36.4%
1701.1%
Net Profit YoY
188.0%
EPS (diluted)
$0.04
$0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
RBKB
RBKB
Q4 25
$23.1M
$13.5M
Q3 25
$15.8M
$14.0M
Q2 25
$18.1M
$13.1M
Q1 25
$17.4M
$12.8M
Q4 24
$16.9M
$750.0K
Q3 24
$18.0M
$773.0K
Q2 24
$17.0M
$10.7M
Q1 24
$17.8M
$10.4M
Net Profit
ADCT
ADCT
RBKB
RBKB
Q4 25
$2.3M
Q3 25
$-41.0M
$2.7M
Q2 25
$-56.6M
$2.7M
Q1 25
$-38.6M
$2.3M
Q4 24
$-2.7M
Q3 24
$-44.0M
$-8.1M
Q2 24
$-36.5M
$975.0K
Q1 24
$-46.6M
$1.1M
Operating Margin
ADCT
ADCT
RBKB
RBKB
Q4 25
-77.7%
21.7%
Q3 25
-196.6%
23.9%
Q2 25
-244.1%
26.6%
Q1 25
-163.5%
22.9%
Q4 24
-191.8%
-444.9%
Q3 24
-197.4%
-1332.3%
Q2 24
-170.5%
11.8%
Q1 24
-188.3%
13.9%
Net Margin
ADCT
ADCT
RBKB
RBKB
Q4 25
17.3%
Q3 25
-260.1%
19.3%
Q2 25
-313.2%
20.8%
Q1 25
-221.8%
17.9%
Q4 24
-353.9%
Q3 24
-244.1%
-1042.9%
Q2 24
-214.6%
9.2%
Q1 24
-261.1%
10.8%
EPS (diluted)
ADCT
ADCT
RBKB
RBKB
Q4 25
$0.04
$0.21
Q3 25
$-0.30
$0.25
Q2 25
$-0.50
$0.25
Q1 25
$-0.36
$0.21
Q4 24
$-0.26
$-0.24
Q3 24
$-0.42
$-0.75
Q2 24
$-0.38
$0.09
Q1 24
$-0.56
$0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
RBKB
RBKB
Cash + ST InvestmentsLiquidity on hand
$261.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-185.8M
$136.9M
Total Assets
$323.1M
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
RBKB
RBKB
Q4 25
$261.3M
Q3 25
$234.7M
Q2 25
$264.6M
Q1 25
$194.7M
Q4 24
$250.9M
Q3 24
$274.3M
Q2 24
$300.1M
Q1 24
$234.3M
Stockholders' Equity
ADCT
ADCT
RBKB
RBKB
Q4 25
$-185.8M
$136.9M
Q3 25
$-238.2M
$133.0M
Q2 25
$-199.2M
$129.0M
Q1 25
$-238.2M
$126.0M
Q4 24
$-202.6M
$121.8M
Q3 24
$-171.9M
$122.7M
Q2 24
$-131.7M
$116.2M
Q1 24
$-194.4M
$114.3M
Total Assets
ADCT
ADCT
RBKB
RBKB
Q4 25
$323.1M
$1.3B
Q3 25
$289.8M
$1.3B
Q2 25
$321.6M
$1.3B
Q1 25
$272.5M
$1.3B
Q4 24
$322.0M
$1.3B
Q3 24
$349.1M
$1.3B
Q2 24
$371.8M
$1.3B
Q1 24
$308.0M
$1.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
RBKB
RBKB
Operating Cash FlowLast quarter
$-31.1M
$11.7M
Free Cash FlowOCF − Capex
$10.9M
FCF MarginFCF / Revenue
80.6%
Capex IntensityCapex / Revenue
0.0%
6.3%
Cash ConversionOCF / Net Profit
5.03×
TTM Free Cash FlowTrailing 4 quarters
$19.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
RBKB
RBKB
Q4 25
$-31.1M
$11.7M
Q3 25
$-29.6M
$2.2M
Q2 25
$-24.1M
$2.4M
Q1 25
$-56.3M
$4.3M
Q4 24
$-21.9M
$8.5M
Q3 24
$-25.0M
$-3.6M
Q2 24
$-32.8M
$12.0M
Q1 24
$-44.1M
$-3.5M
Free Cash Flow
ADCT
ADCT
RBKB
RBKB
Q4 25
$10.9M
Q3 25
$2.0M
Q2 25
$2.2M
Q1 25
$-56.6M
$4.2M
Q4 24
$-21.9M
$7.7M
Q3 24
$-25.3M
$-3.6M
Q2 24
$-32.9M
$11.8M
Q1 24
$-44.6M
$-3.7M
FCF Margin
ADCT
ADCT
RBKB
RBKB
Q4 25
80.6%
Q3 25
14.5%
Q2 25
17.2%
Q1 25
-325.2%
32.8%
Q4 24
-129.8%
1023.9%
Q3 24
-140.2%
-469.0%
Q2 24
-193.0%
111.1%
Q1 24
-250.0%
-36.0%
Capex Intensity
ADCT
ADCT
RBKB
RBKB
Q4 25
0.0%
6.3%
Q3 25
0.0%
1.4%
Q2 25
0.0%
1.4%
Q1 25
1.5%
0.9%
Q4 24
0.5%
105.5%
Q3 24
1.2%
6.3%
Q2 24
0.2%
1.2%
Q1 24
3.0%
2.3%
Cash Conversion
ADCT
ADCT
RBKB
RBKB
Q4 25
5.03×
Q3 25
0.83×
Q2 25
0.89×
Q1 25
1.89×
Q4 24
Q3 24
Q2 24
12.27×
Q1 24
-3.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons